{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:33Z","timestamp":1792788333540,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Scientific and Technological Research Council of T\u00fcrkiye","award":["117S241"],"award-info":[{"award-number":["117S241"]}],"id":[{"id":"https:\/\/ror.org\/04w9kkr77","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03496-2","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:45:26Z","timestamp":1790192726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intranasal Delivery of Solid Lipid Nanoparticles Loaded with Carmustine and Temozolomide for Glioblastoma Treatment in Mice"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2673-7321","authenticated-orcid":false,"given":"Ay\u015fe","family":"\u00dcnal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9613-6348","authenticated-orcid":false,"given":"G\u00fcliz","family":"Ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1106-0458","authenticated-orcid":false,"given":"Habibe","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu\u011fba Karakayal\u0131","family":"Kavruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3029-9560","authenticated-orcid":false,"given":"Ay\u00e7a","family":"Erek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2938-578X","authenticated-orcid":false,"given":"Re\u015fat Serhat","family":"Erbayraktar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0316-1462","authenticated-orcid":false,"given":"Z\u00fcbeyde","family":"Erbayraktar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8015-9916","authenticated-orcid":false,"given":"Ay\u00e7a Er\u015fen","family":"Danyeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2659-4129","authenticated-orcid":false,"given":"Buket","family":"\u00d6zel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0612-2263","authenticated-orcid":false,"given":"Nur Selvi","family":"G\u00fcnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8199-6051","authenticated-orcid":false,"given":"Derya","family":"Er\u0131\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4016-0522","authenticated-orcid":false,"given":"Yi\u011fit","family":"Uyan\u0131kgil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3173-1389","authenticated-orcid":false,"given":"Nuriye Nuray","family":"Ulusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6449-2708","authenticated-orcid":false,"given":"Duygu","family":"Aydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0887-0302","authenticated-orcid":false,"given":"Hayal","family":"Boyac\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6532-7221","authenticated-orcid":false,"given":"\u015eenay","family":"\u015eanl\u0131er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"issue":"9","key":"3496_CR1","doi-asserted-by":"publisher","first-page":"e07994","DOI":"10.1016\/j.heliyon.2021.e07994","volume":"7","author":"H Nsairat","year":"2021","unstructured":"Nsairat H, Khater D, Odeh F, Al-Adaliah F, Al-Taher S, Jaber AM, et al. Lipid nanostructures for targeting brain cancer. Heliyon. 2021Sep 16;7(9):e07994.","journal-title":"Heliyon"},{"issue":"1","key":"3496_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2005;2(1):3\u201314.","journal-title":"NeuroRx"},{"issue":"8","key":"3496_CR3","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1002\/cam4.775","volume":"5","author":"A Shea","year":"2016","unstructured":"Shea A, Harish V, Afzal Z, Chijioke J, Kedir H, Dusmatova S, et al. MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics. Cancer Med. 2016;5(8):1917\u201346.","journal-title":"Cancer Med"},{"issue":"10","key":"3496_CR4","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u201396.","journal-title":"N Engl J Med"},{"key":"3496_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.wneu.2018.04.022","volume":"116","author":"EK Noch","year":"2018","unstructured":"Noch EK, Ramakrishna R, Magge R. Challenges in the treatment of glioblastoma: multisystem mechanisms of therapeutic resistance. World Neurosurg. 2018;116:505\u201317.","journal-title":"World Neurosurg"},{"issue":"4","key":"3496_CR6","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00701-023-05544-3","volume":"165","author":"G Chehade","year":"2023","unstructured":"Chehade G, Lawson TM, Lelotte J, Daoud L, Di Perri D, Whenham N, et al. Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics. Acta Neurochir (Wien). 2023;165(4):1075\u201385.","journal-title":"Acta Neurochir (Wien)"},{"key":"3496_CR7","unstructured":"Yu J, Ghiaseddin A, Ahluwalia M. Glioblastoma. American Brain Tumor Association [Internet]. 2022. Available from: https:\/\/www.abta.org\/tumor_types\/glioblastoma-gbm\/. Accessed 1 Apr 2024."},{"issue":"9","key":"3496_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2377-9-33","volume":"1","author":"J Vesper","year":"2009","unstructured":"Vesper J, Graf E, Wille C, Tilger J, Trippel M, Nikkhah G, et al. Retrospective analysis of treatment outcome in 315 patients with oligodendroglial brain tumors. BMC Neurol. 2009;1(9):33.","journal-title":"BMC Neurol"},{"issue":"3","key":"3496_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06502","volume":"7","author":"R Chaudhary","year":"2021","unstructured":"Chaudhary R. Potential of long non-coding RNAs as a therapeutic target and molecular markers in glioblastoma pathogenesis. Heliyon. 2021;7(3): e06502.","journal-title":"Heliyon"},{"issue":"12","key":"3496_CR10","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ph6121475","volume":"6","author":"Y Ramirez","year":"2013","unstructured":"Ramirez Y, Weatherbee JL, Wheelhouse RT, Ross AH. Glioblastoma multiforme therapy and mechanisms of resistance. Pharmaceuticals (Basel). 2013;6(12):1475\u2013506.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"23","key":"3496_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312697","volume":"22","author":"MJ Sekeres","year":"2021","unstructured":"Sekeres MJ, Bradley-Garcia M, Martinez-Canabal A, Winocur G. Chemotherapy-induced cognitive impairment and hippocampal neurogenesis: a review of physiological mechanisms and interventions. Int J Mol Sci. 2021;22(23): 12697.","journal-title":"Int J Mol Sci"},{"key":"3496_CR12","unstructured":"Mamati, T. (2006). Glioblastoma multiforme\u2019de konkomitant ve adjuvant temozolomid\u2019in radyoterapiye katk\u0131s\u0131 [The contribution of concomitant and adjuvant temozolomide to radiotherapy in glioblastoma multiforme] (Unpublished specialization thesis). Okmeydan\u0131 Training and Research Hospital, \u0130stanbul, Turkey."},{"key":"3496_CR13","doi-asserted-by":"crossref","unstructured":"Jangid, A. K., Jain, P., Pooja, D., & Kulhari, H. (2021). Introduction to nanomedicines: Basic concept and applications. In Emerging trends in nanomedicine (pp. 1\u201323). Springer, Singapore.","DOI":"10.1007\/978-981-15-9920-0_1"},{"key":"3496_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/869269","author":"RK Upadhyay","year":"2014","unstructured":"Upadhyay RK. Drug delivery systems, CNS protection, and the blood brain barrier. BioMed Res Int. 2014. https:\/\/doi.org\/10.1155\/2014\/869269.","journal-title":"BioMed Res Int"},{"issue":"1","key":"3496_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","volume":"11","author":"L Illum","year":"2000","unstructured":"Illum L. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci. 2000;11(1):1\u201318.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"3496_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11019-016-9720-7","volume":"20","author":"I Allon","year":"2017","unstructured":"Allon I, Ben-Yehudah A, Dekel R, Solbakk JH, Weltrick KM, Siegal G, et al. Ethical issues in nanomedicine: tempest in a teapot? Med Health Care Philos. 2017;20(1):3\u201311.","journal-title":"Med Health Care Philos"},{"issue":"3","key":"3496_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1039\/C8MH00966J","volume":"6","author":"KD Patel","year":"2019","unstructured":"Patel KD, Singh RK, Kim H. Carbon-based nanomaterials as an emerging platform for theranostics. Mater Horiz. 2019;6(3):434\u201369.","journal-title":"Mater Horiz"},{"issue":"2","key":"3496_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1208\/s12249-014-0073-3","volume":"15","author":"N Mody","year":"2014","unstructured":"Mody N, Tekade R, Mehra N, Chopdey P, Jain N. Dendrimer, liposomes, carbon nanotubes, and PLGA nanoparticles: one platform assessment of drug delivery potential. AAPS PharmSciTech. 2014;15(2):388\u201399.","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"3496_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ma15020682","volume":"15","author":"E Musielak","year":"2022","unstructured":"Musielak E, Feliczak-Guzik A, Nowak I. Synthesis and potential applications of lipid nanoparticles in medicine. Materials (Basel). 2022;15(2): 682.","journal-title":"Materials (Basel)"},{"key":"3496_CR20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jconrel.2020.02.027","volume":"321","author":"F Oroojalian","year":"2020","unstructured":"Oroojalian F, Charbgoo F, Hashemi M, Amani A, Yazdian-Robati R, Mokhtarzadeh A, et al. Recent advances in nanotechnology-based drug delivery systems for the kidney. J Control Release. 2020;321:442\u201362.","journal-title":"J Control Release"},{"issue":"2\u20133","key":"3496_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","volume":"47","author":"W Mehnert","year":"2001","unstructured":"Mehnert W, M\u00e4der K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47(2\u20133):165\u201396.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"3496_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd4519","volume":"14","author":"M Srinivasarao","year":"2015","unstructured":"Srinivasarao M, Galliford C, Low P. Principles in the design of ligand-targeted cancer therapeutics and imaging agents. Nat Rev Drug Discov. 2015;14(3):203\u201319.","journal-title":"Nat Rev Drug Discov"},{"issue":"14","key":"3496_CR23","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.3390\/cancers13143468","volume":"13","author":"V Miranda-Goncalves","year":"2021","unstructured":"Miranda-Goncalves V, Goncalves C, Granja S, Virira de Castro J, Reis RM, Costa BM, et al. MCT1 is a new prognostic biomarker and its therapeutic inhibition boosts response to temozolomide in human glioblastoma. Cancers (Basel). 2021 Jul 14;13(14):3504.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"3496_CR24","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1172\/JCI105650","volume":"46","author":"OE Owen","year":"1967","unstructured":"Owen OE, Morgan A, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr. Brain metabolism during fasting. J Clin Invest. 1967;46(10):1589\u201395.","journal-title":"J Clin Invest"},{"issue":"8","key":"3496_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-017-0991-5","volume":"34","author":"RJ Klement","year":"2017","unstructured":"Klement RJ. Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation. Med Oncol. 2017;34(8): 132.","journal-title":"Med Oncol"},{"issue":"7","key":"3496_CR26","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/ijc.28809","volume":"135","author":"A Poff","year":"2014","unstructured":"Poff A, Ari C, Arnold P, Seyfried T, D\u2019Agostino D. Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer. Int J Cancer. 2014;135(7):1711\u201320.","journal-title":"Int J Cancer"},{"key":"3496_CR27","doi-asserted-by":"publisher","first-page":"111946","DOI":"10.1016\/j.colsurfb.2021.111946","volume":"206","author":"G Ak","year":"2021","unstructured":"Ak G, \u00dcnal A, Karakayali T, Ozel B, Gunel N, Sanlier S. Brain-targeted, drug-loaded solid lipid nanoparticles against glioblastoma cells in culture. Colloids Surf B Biointerfaces. 2021;206:111946.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"3496_CR28","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.xphs.2018.10.030","volume":"108","author":"\u015e Hamarat \u015eanl\u0131er","year":"2019","unstructured":"Hamarat \u015eanl\u0131er \u015e, Ak G, Y\u0131lmaz H, \u00dcnal A, Bozkaya \u00dcF, Tan\u0131yan G, et al. Development of ultrasound-triggered and magnetic-targeted nanobubble system for dual-drug delivery. J Pharm Sci. 2019;108(3):1272\u201383.","journal-title":"J Pharm Sci"},{"key":"3496_CR29","first-page":"4440","volume":"74","author":"L Hanson","year":"2013","unstructured":"Hansen L, Fine J, Svitak A, Faltesek K. Intranasal administration of CNS therapeutics to awake mice. J Vis Exp. 2013;74:4440.","journal-title":"J Vis Exp"},{"issue":"5","key":"3496_CR30","doi-asserted-by":"publisher","first-page":"184954351880535","DOI":"10.1177\/1849543518805355","volume":"28","author":"A De","year":"2018","unstructured":"De A, Venkatesh N, Senthil M, Reddy Sanapalli BK, Shanmugham R, Reddy Karri VVS, et al. Smart niosomes of temozolomide for enhancement of brain targeting. Nanobiomedicine (Rijeka). 2018;28(5):1849543518805355.","journal-title":"Nanobiomedicine (Rijeka)"},{"issue":"11","key":"3496_CR31","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1021\/acs.molpharmaceut.6b00586","volume":"13","author":"A Khan","year":"2016","unstructured":"Khan A, Imam S, Aqil M, Ahad A, Sultana Y, Ali A, et al. Brain targeting of temozolomide via the intranasal route using lipid-based nanoparticles: brain pharmacokinetic and scintigraphic analyses. Mol Pharm. 2016;13(11):3773\u201382.","journal-title":"Mol Pharm"},{"issue":"1","key":"3496_CR32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1158\/1078-0432.CCR-19-1739","volume":"26","author":"E Gerstner","year":"2020","unstructured":"Gerstner E, Emblem KE, Chang K, Vakulenko-Lagun B, Yen YF, Beers AL, et al. Bevacizumab reduces permeability and concurrent temozolomide delivery in a subset of patients with recurrent glioblastoma. Clin Cancer Res. 2020;26(1):206\u201312.","journal-title":"Clin Cancer Res"},{"key":"3496_CR33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2478\/jomb-2018-0013","volume":"38","author":"D Aydemir","year":"2019","unstructured":"Aydemir D, Sarayloo E, Ulusu NN. Rosiglitazone-induced changes in the oxidative stress metabolism and fatty acid composition in relation with trace element status in the primary adipocytes. J Med Biochem. 2019;38:38.","journal-title":"J Med Biochem."},{"issue":"12","key":"3496_CR34","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.1007\/s12011-021-02585-6","volume":"199","author":"M Ozcan","year":"2021","unstructured":"Ozcan M, Aydemir D, Bacanl\u0131 M, et al. Protective effects of antioxidant chlorophyllin in chemically induced breast cancer model in vivo. Biol Trace Elem Res. 2021;199(12):4475\u201388.","journal-title":"Biol Trace Elem Res"},{"key":"3496_CR35","first-page":"445","volume":"6","author":"XH Tian","year":"2011","unstructured":"Tian XH, Lin XN, Wei F, Feng W, Huang ZC, Wang P, et al. Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles. Int J Nanomed. 2011;6:445\u201352.","journal-title":"Int J Nanomed"},{"issue":"19","key":"3496_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/app11199336","volume":"11","author":"V Ravichandran","year":"2021","unstructured":"Ravichandran V, Lee M, Nguyen Cao TG, Shim MS. Polysorbate-based drug formulations for brain-targeted drug delivery and anticancer therapy. Appl Sci. 2021;11(19):9336.","journal-title":"Appl Sci"},{"issue":"3","key":"3496_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5582\/ddt.2015.01016","volume":"9","author":"J Gao","year":"2015","unstructured":"Gao J, Wang Z, Liu H, Wang L, Huang G, et al. Liposome encapsulated temozolomide for the treatment of glioma tumor: preparation, characterization and evaluation. Drug Discov Ther. 2015;9(3):205\u201312.","journal-title":"Drug Discov Ther"},{"issue":"3","key":"3496_CR38","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3892\/ijmm.2016.2458","volume":"37","author":"J Hu","year":"2016","unstructured":"Hu J, Wang J, Wang G, Yao Z, Dang X. Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells. Int J Mol Med. 2016;37(3):690\u2013702.","journal-title":"Int J Mol Med"},{"issue":"3","key":"3496_CR39","first-page":"46","volume":"42","author":"LM Serfilippi","year":"2003","unstructured":"Serfilippi LM, Pallman DRS, Russell B. Serum clinical chemistry and hematology reference values in outbred stocks of albino mice from three commonly used vendors and two inbred strains of albino mice. J Am Assoc Lab Anim Sci. 2003;42(3):46\u201352.","journal-title":"J Am Assoc Lab Anim Sci"},{"issue":"22","key":"3496_CR40","doi-asserted-by":"publisher","first-page":"7092","DOI":"10.1158\/1078-0432.CCR-09-1349","volume":"15","author":"J Portnow","year":"2009","unstructured":"Portnow J, Badie B, Chen M, Liu A, Blanchard S, Synold TW. The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation. Clin Cancer Res. 2009;15(22):7092\u20138.","journal-title":"Clin Cancer Res"},{"key":"3496_CR41","unstructured":"Uyan\u0131kgil, Y. (2006). Intrauterinal kortikal displazi modeli olu\u015fturulan yenido\u011fan s\u0131\u00e7anlarda cerebellar korteks \u00fczerine maternal melatonin etkisinin incelenmesi [Investigation of maternal melatonin effect on cerebellar cortex in newborn rats with intrauterine cortical dysplasia model] (Doctoral dissertation, Ege University, \u0130zmir, Turkey)."},{"key":"3496_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jconrel.2019.07.033","volume":"309","author":"F Sousa","year":"2019","unstructured":"Sousa F, Dhaliwal HK, Gattacceca F, Sarmento B, Amiji MM. Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles. J Control Release. 2019;309:37\u201347.","journal-title":"J Control Release"},{"issue":"5-6","key":"3496_CR43","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1080\/1061186X.2019.1567738","volume":"27","author":"LP Ganipineni","year":"2019","unstructured":"Ganipineni LP, Ucakar B, Joudiou N, Riva R, J\u00e9r\u00f4me C, Gallez B, et al. Paclitaxel-loaded multifunctional nanoparticles for the targeted treatment of glioblastoma. J Drug Target. 2019;27(5\u20136):614\u201323.","journal-title":"J Drug Target"},{"issue":"9","key":"3496_CR44","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1080\/10717544.2016.1189465","volume":"23","author":"J Qu","year":"2016","unstructured":"Qu J, Zhang L, Chen Z, Mao G, Gao Z, Lai X, et al. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy? Drug Deliv. 2016;23(9):3408\u201316.","journal-title":"Drug Deliv"},{"issue":"1","key":"3496_CR45","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/s41598-020-57707-2","volume":"10","author":"A Otahal","year":"2020","unstructured":"Otahal A, Aydemir D, Tomasich E, Minichsdorfer C. Delineation of cell death mechanisms induced by synergistic effects of statins and erlotinib in non-small cell lung cancer cell (NSCLC) lines. Sci Rep. 2020;10(1):959.","journal-title":"Sci Rep"},{"key":"3496_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.589570","volume":"11","author":"G Batsios","year":"2021","unstructured":"Batsios G, Taglang C, Cao P, et al. Imaging 6-phosphogluconolactonase activity in brain tumors in vivo using hyperpolarized \u03b4-[1-13C]gluconolactone. Front Oncol. 2021;11:589570.","journal-title":"Front Oncol"},{"issue":"5","key":"3496_CR47","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/15257770.2021.1897457","volume":"40","author":"D Aydemir","year":"2021","unstructured":"Aydemir D, Da\u011fl\u0131o\u011flu G, Candevir A, et al. COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients. Nucleosides Nucleotides Nucleic Acids. 2021;40(5):505\u201317.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"1","key":"3496_CR48","first-page":"17","volume":"4","author":"N Singh","year":"2021","unstructured":"Singh N, Miner A, Hennis L, Mittal S. Mechanisms of temozolomide resistance in glioblastoma \u2013 a comprehensive review. Cancer Drug Resist. 2021;4(1):17\u201361.","journal-title":"Cancer Drug Resist"},{"issue":"12","key":"3496_CR49","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1021\/bc200406n","volume":"22","author":"J Jin","year":"2011","unstructured":"Jin J, Bae KH, Yang H, Lee SJ, Kim H, Kim Y, et al. In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles. Bioconjug Chem. 2011;22(12):2568\u201372.","journal-title":"Bioconjug Chem"},{"key":"3496_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105136","volume":"149","author":"JA Campos-Sandoval","year":"2021","unstructured":"Campos-Sandoval JA, G\u00f3mez-Garc\u00eda MC, Santos-Jim\u00e9nez J, Mates JM, Alonso FJ, Marquez J. Antioxidant responses related to temozolomide resistance in glioblastoma. Neurochem Int. 2021;149: 105136.","journal-title":"Neurochem Int"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03496-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03496-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03496-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:45:29Z","timestamp":1790192729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03496-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3496"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03496-2","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no conflicts of interest in this work.","order":1,"name":"Ethics","label":"Conflict of Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"310"}}